Adamas Pharmaceuticals Inc Price to Earnings Ratio (PE) Ratios, (ADMS) Valuation Ranking and Trends, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
• P/E Ratio TTM
• P/S Ratio TTM
• P/CF Ratio TTM
• P/FCF Ratio TTM
• Price to Book MRQ
• Price to Tangible Book

Adamas Pharmaceuticals Inc  (NASDAQ: ADMS)
 



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

About ADMS >> Compare ADMS Price to Earnings Ratio to its Competitors >> Return to ADMS Valuation Comparisons

ADMS Price to Earnings Ratio Current (Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Diluted EPS 12 Trailing Months II. Quarter I. Quarter IV. Quarter III. Quarter
PE (TTM) Ratio current            -            -            -            -            -
Diluted EPS TTM Y / Y Change -22.52 % -38.79 % -45.57 % -46.54 % -45.37 %
Diluted EPS Y / Y Change 2.38 % -27.03 % -38.98 % -21.41 % -57.58 %
Stock performance to date 47.31 % 2.52 % 7.14 % 1.17 % 51.47 %

Price to earnings ratio Comment
Adamas Pharmaceuticals Inc's recorded net loss in trailing twelve months.

Within Healthcare sector 17 other companies have lower Price to earnings ratio.

What is Price to Earnings Ratio?
What is Adamas Pharmaceuticals Inc Market Share?

Price to earnings ratio Company Ranking
Within: No.
Industry #13
Sector #18
S&P 500 #51





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.